NL9201716A - Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. - Google Patents
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. Download PDFInfo
- Publication number
- NL9201716A NL9201716A NL9201716A NL9201716A NL9201716A NL 9201716 A NL9201716 A NL 9201716A NL 9201716 A NL9201716 A NL 9201716A NL 9201716 A NL9201716 A NL 9201716A NL 9201716 A NL9201716 A NL 9201716A
- Authority
- NL
- Netherlands
- Prior art keywords
- omp
- outer membrane
- saccharide
- polypeptide
- membrane vesicle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9201716A NL9201716A (nl) | 1992-10-02 | 1992-10-02 | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
| ES93921120T ES2289739T3 (es) | 1992-10-02 | 1993-07-30 | Liposacarido meningococico inmunogenico y vesiculas de membrana externa y vacunas de los mismos. |
| EP93921120A EP0680512B1 (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| PT93921120T PT680512E (pt) | 1992-10-02 | 1993-07-30 | Uma molécula provida de imunidade activadora das células e derivada de um lipopolissacarídeo meningocócico, métodos para a sua preparação, uma vesícula de membrana externa provida com grupo de polipepetídeos |
| US08/411,727 US5705161A (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| JP6508917A JPH08501940A (ja) | 1992-10-02 | 1993-07-30 | 免疫原性髄膜炎菌のlpsと外膜小胞とそれからのワクチン |
| AT93921120T ATE364702T1 (de) | 1992-10-02 | 1993-07-30 | Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus |
| AU48351/93A AU684720B2 (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal LPS and outer membrane vesicles and vaccine therefrom |
| DE69334147T DE69334147T2 (de) | 1992-10-02 | 1993-07-30 | Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus |
| DK93921120T DK0680512T3 (da) | 1992-10-02 | 1993-07-30 | Immunogent meningokok LPS og ydermembranvesikler og vaccine deraf |
| CA002146145A CA2146145C (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| PCT/NL1993/000163 WO1994008021A1 (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| FI951535A FI951535L (fi) | 1992-10-02 | 1993-07-30 | Immunogeeninen meningokokki -LPS ja siitä saadut ulkomembraanirakkulat ja rokote |
| NO19951181A NO321651B1 (no) | 1992-10-02 | 1995-03-28 | Immunogent meningokokk-lipopoly-sakkarid, ytter-membranvesikler, samt vaksine fremstilt derav. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9201716 | 1992-10-02 | ||
| NL9201716A NL9201716A (nl) | 1992-10-02 | 1992-10-02 | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL9201716A true NL9201716A (nl) | 1994-05-02 |
Family
ID=19861338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL9201716A NL9201716A (nl) | 1992-10-02 | 1992-10-02 | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5705161A (da) |
| EP (1) | EP0680512B1 (da) |
| JP (1) | JPH08501940A (da) |
| AT (1) | ATE364702T1 (da) |
| AU (1) | AU684720B2 (da) |
| CA (1) | CA2146145C (da) |
| DE (1) | DE69334147T2 (da) |
| DK (1) | DK0680512T3 (da) |
| ES (1) | ES2289739T3 (da) |
| FI (1) | FI951535L (da) |
| NL (1) | NL9201716A (da) |
| NO (1) | NO321651B1 (da) |
| PT (1) | PT680512E (da) |
| WO (1) | WO1994008021A1 (da) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| US20020028215A1 (en) | 1999-08-09 | 2002-03-07 | Jagath L. Kadurugamuwa | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
| BR9609882A (pt) * | 1995-08-04 | 1999-07-27 | Univ Guelph | Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana |
| US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
| US6645503B1 (en) * | 1998-03-10 | 2003-11-11 | Wyeth Holdings Corporation | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
| GB9823978D0 (en) | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| US6531131B1 (en) | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
| EP2364726A3 (en) * | 1999-09-30 | 2011-11-09 | Isis Innovation Limited | Vaccine against neisseria infection |
| MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
| AU2003239125A1 (en) * | 2002-03-20 | 2003-10-08 | Emory University | Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| CN1674933B (zh) * | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| RU2364418C2 (ru) * | 2002-08-02 | 2009-08-20 | ГлаксоСмитКлайн Байолоджикалз с.а. | ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB- |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| EP2351579B1 (en) | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| CA2506318C (en) | 2002-11-15 | 2011-07-12 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| DK1587537T3 (da) | 2003-01-30 | 2012-07-16 | Novartis Ag | Injicerbare vacciner mod multiple meningococ-serogrupper |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| US7537766B2 (en) * | 2004-08-30 | 2009-05-26 | Wyeth | Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| ES2337309T5 (es) | 2006-06-12 | 2013-07-30 | Glaxosmithkline Biologicals S.A. | Vacuna |
| AU2009215364B2 (en) | 2008-02-21 | 2014-09-18 | Glaxosmithkline Biologicals S.A. | Meningococcal fHBP polypeptides |
| MX2010012999A (es) * | 2008-05-30 | 2012-03-07 | U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. |
| CN104548082A (zh) | 2009-03-24 | 2015-04-29 | 诺华股份有限公司 | 为脑膜炎球菌因子h结合蛋白添加佐剂 |
| EP3017826A1 (en) | 2009-03-24 | 2016-05-11 | Novartis AG | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| WO2010130898A2 (fr) * | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6 |
| WO2010134225A1 (ja) * | 2009-05-20 | 2010-11-25 | 国立大学法人鳥取大学 | 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン |
| AU2010288239B2 (en) | 2009-08-27 | 2014-01-16 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
| WO2011024072A2 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
| CN102724988B (zh) | 2009-09-30 | 2014-09-10 | 诺华股份有限公司 | 脑膜炎球菌fHBP多肽的表达 |
| CA2779816A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| WO2012020326A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
| WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
| EP2797624A1 (en) | 2011-12-29 | 2014-11-05 | Novartis AG | Adjuvanted combinations of meningococcal factor h binding proteins |
| CN106661092B (zh) | 2014-02-28 | 2021-07-06 | 葛兰素史密丝克莱恩生物有限公司 | 修饰的脑膜炎球菌fHbp多肽 |
| GB201712824D0 (en) | 2017-08-10 | 2017-09-27 | Glaxosmithkline Biologicals Sa | Multi-functionalized nOMV Conjugates |
| BR112021002710A2 (pt) | 2018-08-14 | 2021-11-16 | Evercyte Gmbh | Vesículas extracelulares específicas alvo (tev), uma preparação, uma proteína de superfície da vesícula extracelular específica alvo, um domínio extravesicular específico alvo da mesma. codificação de ácido nucleico, biblioteca de tev, preparação farmacêutica e sua utilização; métodos de produção |
| AU2022208435A1 (en) | 2021-01-18 | 2023-08-10 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU640118B2 (en) * | 1988-12-19 | 1993-08-19 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Meningococcal class 1 outer-membrane protein vaccine |
| NL9101359A (nl) * | 1991-08-07 | 1993-03-01 | Nederlanden Staat | Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat. |
-
1992
- 1992-10-02 NL NL9201716A patent/NL9201716A/nl not_active Application Discontinuation
-
1993
- 1993-07-30 WO PCT/NL1993/000163 patent/WO1994008021A1/en not_active Ceased
- 1993-07-30 ES ES93921120T patent/ES2289739T3/es not_active Expired - Lifetime
- 1993-07-30 US US08/411,727 patent/US5705161A/en not_active Expired - Lifetime
- 1993-07-30 JP JP6508917A patent/JPH08501940A/ja active Pending
- 1993-07-30 AT AT93921120T patent/ATE364702T1/de active
- 1993-07-30 CA CA002146145A patent/CA2146145C/en not_active Expired - Lifetime
- 1993-07-30 AU AU48351/93A patent/AU684720B2/en not_active Ceased
- 1993-07-30 FI FI951535A patent/FI951535L/fi unknown
- 1993-07-30 EP EP93921120A patent/EP0680512B1/en not_active Expired - Lifetime
- 1993-07-30 DE DE69334147T patent/DE69334147T2/de not_active Expired - Lifetime
- 1993-07-30 PT PT93921120T patent/PT680512E/pt unknown
- 1993-07-30 DK DK93921120T patent/DK0680512T3/da active
-
1995
- 1995-03-28 NO NO19951181A patent/NO321651B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT680512E (pt) | 2007-09-25 |
| NO321651B1 (no) | 2006-06-19 |
| DE69334147T2 (de) | 2008-02-14 |
| AU684720B2 (en) | 1998-01-08 |
| AU4835193A (en) | 1994-04-26 |
| JPH08501940A (ja) | 1996-03-05 |
| NO951181D0 (no) | 1995-03-28 |
| US5705161A (en) | 1998-01-06 |
| CA2146145C (en) | 2009-10-27 |
| EP0680512A1 (en) | 1995-11-08 |
| DK0680512T3 (da) | 2007-10-01 |
| ATE364702T1 (de) | 2007-07-15 |
| ES2289739T3 (es) | 2008-02-01 |
| FI951535A7 (fi) | 1995-06-01 |
| EP0680512B1 (en) | 2007-06-13 |
| WO1994008021A1 (en) | 1994-04-14 |
| NO951181L (no) | 1995-06-01 |
| FI951535L (fi) | 1995-06-01 |
| CA2146145A1 (en) | 1994-04-14 |
| DE69334147D1 (de) | 2007-07-26 |
| FI951535A0 (fi) | 1995-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2146145C (en) | Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom | |
| JP3436756B2 (ja) | 髄膜炎菌のクラスiの外膜タンパク質のワクチン | |
| Masignani et al. | Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 | |
| RU2181378C2 (ru) | Способ высокоуровневой экспрессии, способ очистки и способ переукладки поринового протеина внешней мембраны менингококка группы в или слитого с ним протеина, высокоочищенный пориновый протеин (варианты), высокоочищенный пориновый слитый протеин (варианты), вакцина для предупреждения бактериального менингита группы в, способ получения конъюгата протеина менингококка группы в и полисахарида, способ предупреждения бактериального менингита, штамм е.coli (варианты) | |
| JP4827196B2 (ja) | 髄膜炎菌類タンパク質nmb1870のドメインおよびエピトープ | |
| US7118757B1 (en) | Meningococcal class 1 outer-membrane protein vaccine | |
| US6613336B2 (en) | Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide | |
| EP0941738B1 (en) | Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteria | |
| US6645503B1 (en) | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria | |
| KR102626831B1 (ko) | 수막구균 백신 | |
| KR20160127104A (ko) | 변형된 수막구균 fhbp 폴리펩티드 | |
| US20230137914A1 (en) | nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF | |
| CA2007248C (en) | Meningococcal class 1 outer-membrane protein vaccine | |
| EP1572729A2 (en) | Mutant protein and refolding method | |
| de Jonge | Opacity Proteins of Neisseria Meningitidis: Structure-function Relationship and Vaccine Potential | |
| CZ200087A3 (cs) | Imunogenní konjugáty obsahující peptin meningokoků skupiny B a polysacharid H. influenzae | |
| MXPA00000556A (en) | Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae | |
| Ganguli | Molecular genetic analysis of capsular polysaccharide biosynthesis genes in Neisseria meningitidis group B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1B | A search report has been drawn up | ||
| BV | The patent application has lapsed |